This inventor holds 3 USPTO granted patents. Top assignee: University of Illinois. Active years: 1984-2004.
Company Filing History:
Years Active: 1984-2004
Title: Alan D Kinghorn: Innovator in Cancer Treatment and Sweetening Agents
Introduction
Alan D Kinghorn is a notable inventor based in Chicago, IL, with a focus on developing innovative solutions in the fields of cancer treatment and sweetening agents. He holds three patents that showcase his contributions to science and technology.
Latest Patents
One of his latest patents is titled "Aromatase inhibitors from Broussonetia papyrifera." This patent discloses a composition and method for cancer treatment utilizing extracts or compounds with aromatase inhibition properties. These agents serve as active cancer chemopreventative and treatment options for mammals, including humans. Another significant patent is for "Low cariogenic sweetening agents," which highlights racemic hernandulcin, a sesquiterpene with a sweetness intensity approximately three orders of magnitude greater than that of sucrose. This compound is non-mutagenic and non-toxic, making it an attractive option for use in foods, beverages, and pharmaceutical compositions, as well as a low-cariogenic sweetening agent for oral hygiene products.
Career Highlights
Throughout his career, Alan has worked with esteemed institutions such as the University of Illinois and The Board of Trustees of the University of Illinois. His work has significantly impacted the fields of cancer research and food science.
Collaborations
Alan has collaborated with notable individuals in his field, including John M Pezzuto and Dongho Lee. Their combined expertise has contributed to the advancement of innovative solutions in their respective areas of research.
Conclusion
Alan D Kinghorn's contributions to cancer treatment and sweetening agents demonstrate his commitment to innovation and scientific advancement. His patents reflect a dedication to improving health and wellness through research and development.